jostae

Do you have any other publications in the fields of HIV and/or vaccine development?

How long ago did you submit the manuscript?

What's the delivery technique for the epitopes, and how is it that you're able to synthesise this HLA-specific sites?

Would it be possible for you to give a brief technical overview of why your vaccine and why it is better/safer/more inclined to work, in contrast to the dozens of others already approved for clinical trials? The best I can gather from the scattered information so far is that you're utilising microspheres, and you "don't use any virus".